Survanta Intratracheal

Survanta Intratracheal is a lung surfactant, also known as a surfactant. It helps the lungs work properly. This medicine is like the natural fluid in the lungs that helps with breathing.

Survanta Intratracheal is used to treat or prevent respiratory distress syndrome (RDS) in a premature baby whose lungs are not fully developed.

Survanta Intratracheal may also be used for reasons not mentioned in this medication guide.

Your baby will receive this medication in a neonatal intensive care unit (NICU) or a similar hospital setting.

Survanta Intratracheal is given directly into the baby's lungs through a breathing tube that is also connected to a ventilator (a machine that helps move air in and out of the lungs so your baby can breathe easier and get enough oxygen).

Your baby will be closely monitored during treatment with Survanta Intratracheal.

Follow your doctor's instructions about any feeding restrictions or other medications after your child has been treated with Survanta Intratracheal.

To help take care of your baby in the NICU, please follow all the instructions given by your baby's caregivers carefully.

There is a chance that the baby may experience breathing difficulties during the Survanta Intratracheal treatment, and these issues might need additional care from health care professionals. Your baby will be closely monitored throughout the treatment with this medicine.

Inform your child's caregivers immediately if the child shows any of these serious side effects:

• pale skin;
• slow heartbeat;
• breathing that stops;
• urinating less than usual; or
• blood in the urine.

Less serious side effects may include:

• noisy breathing;
• feeding or bowel problems; or
• bleeding around the endotracheal tube.

This is not a complete list of side effects, and others may happen. Contact your doctor for medical advice regarding side effects. You can report side effects to the FDA at 1-800-FDA-1088.

Survanta Intratracheal is given directly into the baby's lungs through a breathing tube. Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

The breathing tube is connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Survanta Intratracheal is given as soon as possible after the baby's birth, usually within minutes or hours.

Your baby's breathing, blood pressure, oxygen levels, and other vital signs will be watched closely during treatment with Survanta Intratracheal. This will help your doctor determine how long to continue treatment with this medicine. Your child may also need blood tests.

Since Survanta Intratracheal is given as needed by a healthcare professional, it is not likely that your baby will miss a dose.

Since Survanta Intratracheal is given in a controlled medical setting by a healthcare professional, an overdose is not likely to happen. However, an overdose of beractant is not expected to cause life-threatening symptoms.

Follow your doctor's instructions about any restrictions in feeding, medications, or activity after your baby has been treated with Survanta Intratracheal.

Your baby's caregivers will handle and keep track of all medications given to your baby during treatment in the NICU. A drug interaction between Survanta Intratracheal and other medications is not expected to happen.

Do not give any medications to your baby that have not been prescribed by the baby's doctor. This includes vitamins, minerals, or herbal products.